How Do Clinicians of Different Specialties Perceive and Use Opioid Risk Mitigation Strategies? A Qualitative Study

Background In response to the opioid crisis, states and health systems are encouraging clinicians to use risk mitigation strategies aimed at assessing a patient’s risk for opioid misuse or abuse: opioid agreements, prescription drug monitoring programs (PDMPs), and urine drug tests (UDT). Objective: The objective of this qualitative study was to understand how clinicians perceived and used risk mitigation strategies for opioid abuse/misuse and identify barriers to implementation. Methods: We interviewed clinicians who prescribe opioid medications in the outpatient setting from 2016-2018 and analyzed the data using Constructivist Grounded Theory methodology. Results: We interviewed 21 primary care clinicians and 12 specialists. Nearly all clinicians reported using the PDMP. Some clinicians (adopters) found the opioid agreement and UDTs to be valuable, but most (non-adopters) did not. Adopters found the agreements and UDTs helpful in treating patients equitably, setting limits, and having objective evidence of misuse; protocols and workflows facilitated the use of the strategies. Non-adopters perceived the strategies as awkward, disruptive to the clinician-patient relationship, and introducing a power differential; they also cited lack of time and resources as barriers to use. Conclusions: Our study demonstrates that clinicians in certain settings have found effective ways to implement and use the PDMP, opioid agreements, and UDT but that other clinicians are less comfortable with their use. Administrators and policymakers should ensure that the strategies are designed in a way that strengthens the clinician-patient relationship while maximizing safety for patients and that clinicians are adequately trained and supported when introducing the strategies

Business · Early adopter · Family medicine · Medical emergency · Medical prescription · Opioid · Opioid use disorder · Prescription Drug Misuse · Psychiatry · Qualitative research · Medicine · Nursing · Opioid Use Disorder Treatment · Prenatal Substance Exposure Effects · Substance Abuse Treatment and Outcomes

• Barriers and facilitators related to healthcare practitioner use of real time prescription monitoring tools in Australia

  Open Access•Dimi Hoppe, Chaojie Liu et al.•Frontiers in Public Health•2023

  Incluir item

• The Coding Manual for Qualitative Researchers

  Johnny Saldaña•The Coding Manual for Qualitative…•2025

  Incluir item

• CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016

  Deborah Dowell, Tamara M Haegerich et al.•JAMA•2016

  Incluir item

• Sampling for qualitative research

  Open Access•Martin Marshall, Martin N Marshall•Family Practice•1996

  Incluir item

• Is Nonconsensual Tapering of High-Dose Opioid Therapy Justifiable

  Open Access•Travis N Rieder•The AMA Journal of Ethic•2020

  Incluir item

• Sampling in Interview-Based Qualitative Research

  O C Robinson•Qualitative Research in Psychology•2013

  Incluir item

• Socioeconomic status, fundamental cause theory, and prescription opioid use behaviors

  Harvey L Nicholson•Sociological Spectrum•2020

  Incluir item